Exicure, Inc. (XCUR)
Largest Insider Buys in Sector
XCUR Stock Price History Chart
XCUR Stock Performance
About Exicure, Inc.
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease …
Insider Activity of Exicure, Inc.
Over the last 12 months, insiders at Exicure, Inc. have bought $711,669 and sold $4.49M worth of Exicure, Inc. stock.
On average, over the past 5 years, insiders at Exicure, Inc. have bought $1.77M and sold $1.62M worth of stock each year.
Highest buying activity among insiders over the last 12 months: DGP Co., Ltd. (10 percent owner) — $711,669.
The last purchase of 237,223 shares for transaction amount of $711,669 was made by DGP Co., Ltd. (10 percent owner) on 2024‑09‑12.
List of Insider Buy and Sell Transactions, Exicure, Inc.
| 2024-09-12 | 10 percent owner | 237,223 26.8832% | $3.00 | $711,669 | +79.74% | |||
| 2024-02-29 | Sale | 10 percent owner | 3.4M 74.1245% | $1.32 | $4.49M | -29.58% | ||
| 2022-12-15 | director | 3.4M – | $1.60 | $5.44M | +23.08% | |||
| 2022-05-19 | 1.47M 1.7441% | $0.19 | $285,151 | -61.43% | ||||
| 2021-12-21 | Sale | 10 percent owner | 1.27M 1.423% | $0.24 | $303,200 | -53.10% | ||
| 2021-08-27 | Chief Accounting Officer | 10,000 0.0114% | $1.38 | $13,800 | -86.04% | |||
| 2020-06-12 | Sale | 10,195 0.012% | $2.83 | $28,852 | -27.64% | |||
| 2020-06-12 | Sale | 10 percent owner | 10,195 0.012% | $2.83 | $28,852 | -27.64% | ||
| 2020-03-13 | director | 291,066 0.3405% | $1.21 | $352,859 | +77.31% | |||
| 2020-03-12 | Chief Financial Officer | 18,248 0.0224% | $1.40 | $25,591 | +60.69% | |||
| 2020-03-12 | 15,000 0.0191% | $1.45 | $21,750 | +60.69% | ||||
| 2019-12-19 | director | 727,000 0.8229% | $2.75 | $2M | -22.94% | |||
| 2019-08-02 | director | 1M 1.0487% | $2.00 | $2M | -15.25% | |||
| 2019-08-02 | director | 250,000 0.2622% | $2.00 | $500,000 | -15.25% | |||
| 2019-08-02 | 25,000 0.0262% | $2.00 | $50,000 | -15.25% | ||||
| 2019-03-22 | 500 0.0012% | $2.30 | $1,150 | +16.00% | ||||
| 2019-03-21 | 1,000 0.0023% | $2.43 | $2,430 | +10.85% | ||||
| 2019-03-19 | Chief Executive Officer | 7,000 0.0158% | $2.40 | $16,800 | +8.33% | |||
| 2019-03-18 | 1,000 0.0023% | $2.40 | $2,400 | +11.11% | ||||
| 2019-03-13 | 2,200 0.005% | $2.50 | $5,500 | +4.00% |
Insider Historical Profitability
| DGP Co., Ltd. | 10 percent owner | 849223 75.1631% | $11.84 | 1 | 1 | |
| Mirkin Chad A. | 11257629 996.3914% | $11.84 | 6 | 1 | +22.72% | |
| Muralidhar Bali | 8449126 747.8161% | $11.84 | 2 | 0 | <0.0001% | |
| WALT DAVID R | director | 2058777 182.2185% | $11.84 | 3 | 0 | <0.0001% |
| Tompkins Mark N. | 1825667 161.5863% | $11.84 | 2 | 0 |